Patients | Blood culture before surgery | Hearth valve culture | Hearth valve sonication | Antibiotic therapy | Biofilm production | Vegetation (Cm) |
---|---|---|---|---|---|---|
N1 | Negative | Negative | S. aureus | Ceftriaxone; Piperacillin/Tazobactam | High | 1.4 |
N2 | MRSA | MRSA | MRSA | Linezolid; Piperacillin/Tazobactam | Moderate | 1.2 |
N3 | S. gallolyticus | Negative | S. gallolyticus | Ceftriaxone; Gentamicin | Moderate | 1.6 |
N4 | S. aureus | Negative | S. aureus | Vancomycin; Meropenem | High | 1.5 |
N5 | E. faecalis | Negative | E. faecalis | Piperacillin-Tazobactam; Ampicillin; Meropenem | High | 2.1 |
N6 | S. gallolyticus | Negative | S. gallolyticus | Piperacillin-Tazobactam; Vancomycin | High | 2.2 |
N7 | Negative | Negative | S. aureus | Ceftriaxone; Vancomycin; Piperacillin/Tazobactam | Moderate | 1.3 |
N8 | E. faecalis | Negative | E. faecalis | Vancomycin | High | 1.8 |